Recent
Oct. 5, 2024
Rare disease advocates guide FDA to better therapies - Chris Andrews, Firefly Fund
A clip from our episode "Can Austin Lead the Race to Solving Rare Diseases with the Founders of the Firefly Fund"
Oct. 4, 2024
Rare disease lights the way for precision medicine - Pam Andrews, Firefly Fund
A clip from our episode "Can Austin Lead the Race to Solving Rare Diseases with the Founders of the Firefly Fund"
Oct. 3, 2024
The future of medicine where every disease is a rare disease - Pam Andrews, Firefly Fund
A clip from our episode "Can Austin Lead the Race to Solving Rare Diseases with the Founders of the Firefly Fund"
Oct. 2, 2024
Can Austin Lead the Race to Solving Rare Diseases with the Founders of the Firefly Fund
Nothing motivates a parent to action like a sick child, and for the Andrews family, words like no and impossible became mere roadblocks on their journey to help their kids. Our guests, Pam and Chris Andrews, founders of the …
Oct. 2, 2024
Can Austin Lead the Race to Solving Rare Diseases with the Founders of the Firefly Fund
Nothing motivates a parent to action like a sick child, and for the Andrews family, words like no and impossible became mere roadblocks on their journey to help their kids. Our guests, Pam and Chris Andrews, founders of the …
Sept. 27, 2024
A newcomer's take on Austin's tech scene - James Burkett, Nufund Venture Group
A clip from our episode "Angel Investing's Evolution and What Austin's Scene Reveals"
Sept. 25, 2024
The SAFE vs Convertible Note Debate for Angel Investors
A clip from our episode "Angel Investing's Evolution and What Austin's Scene Reveals"
Sept. 24, 2024
Angel Investing's Evolution and What Austin's Scene Reveals
Angel investors are supposed to descend and bring early grace to startups but the reality of angel investing is much more complicated and complex. From individual big-check writers to small investors to organized groups, the…
Sept. 24, 2024
Angels, Super Angels, Angel Groups, Oh My! - Hall Martin, Ten Capital
A clip from our episode "Angel Investing's Evolution and What Austin's Scene Reveals"
Sept. 24, 2024
Angel Investing's Evolution and What Austin's Scene Reveals
Angel investors are supposed to descend and bring early grace to startups but the reality of angel investing is much more complicated and complex. From individual big-check writers to small investors to organized groups, the…
Sept. 22, 2024
Angel Investors are More than a Check - Katie Russell, Central Texas Angel Network
A clip from our episode "Angel Investing's Evolution and What Austin's Scene Reveals"
Sept. 21, 2024
Why Real Time Learning is Crucial for Truly Intelligent AI
A clip from our episode "Artificial General Intelligence Modeled on the Human Mind with Peter Voss"
Sept. 18, 2024
Artificial General Intelligence Modeled on the Human Mind with Peter Voss
Are we overlooking the most powerful model of intelligence we have in our race to create smarter machines, the human mind? Peter Voss, CEO and Chief Scientist of Aigo.ai, coined the term "Artificial General Intelligence" …
Sept. 18, 2024
What is Artificial General Intelligence?
A clip from our episode "Artificial General Intelligence Modeled on the Human Mind with Peter Voss"
Sept. 18, 2024
Artificial General Intelligence Modeled on the Human Mind with Peter Voss
Are we overlooking the most powerful model of intelligence we have in our race to create smarter machines, the human mind? Peter Voss, CEO and Chief Scientist of Aigo.ai, coined the term "Artificial General Intelligence" …
Listen On
Recent Blog Posts
New Report says Austin is turning into life sciences "superstar" hub
Thrilled to have been featured on 'Tech this Out' with Walt Maciborski, discussing the booming Austin Life Sciences Sector!Our report, 'Austin Life Sciences Sector: A Powerhouse Emerging at a Pivotal Crossroads,' was born from a desire to catalyze a…
Austin's Venture Funding Challenges the Global Stagnation
The global venture funding landscape narrative for the first half of 2023 has been portrayed as one of stagnation. Headlines from notable publications, such as Crunchbase's "AI Was Q2’s Big Hope To Reverse The Global Venture Funding Slowdown. …
Austin Life Sciences Sector: A Powerhouse Emerging at a Pivotal Crossroads
Welcome to Austin Next, where we explore Austin's ascension into a global innovation powerhouse. We delve into the region's evolution, examine the building of robust ecosystems, and consider the impact of emerging trends and technologies. With Austi…
About the Host
Jason Scharf
Founder & Host
Jason Scharf has spent nearly two decades pursuing his life’s mission of catalyzing innovation. As an early stage investor, he targets the bio innovation tech stack and the business of health. He has held key leadership roles in strategy and market intelligence at industry pillars such as Illumina, BD, and Amgen. Through the Austin Next podcast and his writings, he explores innovation, Bio & Health, tech, ecosystems, Austin, and their convergence.